Form 8-K - Current report:
SEC Accession No. 0001564590-21-032551
Filing Date
2021-06-11
Accepted
2021-06-11 07:00:29
Documents
7
Period of Report
2021-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imra-8k_20210611.htm 8-K 37047
2 EX-10.1 imra-ex101_15.htm EX-10.1 179135
3 EX-99.1 imra-ex991_29.htm EX-99.1 44642
4 GRAPHIC gxm0sj2ico3y000002.jpg GRAPHIC 171463
5 GRAPHIC gxm0sj2ico3y000001.jpg GRAPHIC 46765
6 GRAPHIC gxm0sj2ico3y000003.jpg GRAPHIC 32219
7 GRAPHIC gn15u54d1kmz000001.jpg GRAPHIC 157340
  Complete submission text file 0001564590-21-032551.txt   812549
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 211009943
SIC: 2834 Pharmaceutical Preparations